Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
Non-suicidal self-injurious behaviors occur with greater frequency in adolescents and young adults. However, clinicians often overlook that adults also engage in these behaviors. Treating non-suicidal self-injurious behavior is critical, as it is associated with a host of negative outcomes including an increased risk for suicide.
 
In this course, you will learn how to identify signs of non-suicidal self-injurious behavior. You will explore the various functions this behavior serves for those who engage in it, and how you can effectively work with individuals to modify these maladaptive coping strategies.
Goals and Outcomes
Goals and Learning Outcomes
The goal of this course is to provide addictions professionals, behavioral health counselors, marriage and family therapists, nurses, psychologists, and social workers in health and human services settings with information on how to identify and treat non-suicidal self-injurious behaviors in adults.
 
This course offers examples of instruments for use when assessing for non-suicidal self-injurious behaviors. The suggestion of specific instruments is not an endorsement. You should explore existing options and bear in mind important issues such as reliability, validity, cost, and training requirements associated with any potential instrument. 
 
DSM™ and DSM-5™ are registered trademarks of the American Psychiatric Association. The American Psychiatric Association is not affiliated with nor endorses this course.
After taking this course, you should be able to:
  • Explain features of non-suicidal self-injury and how the behaviors can develop.
  • Describe how to assess for and identify signs of non-suicidal self-injurious behavior in adults.
  • List the functions of non-suicidal self-injurious behaviors among adults who engage in these behaviors.
  • Identify evidence-based interventions that can be used to treat adults who engage in non-suicidal self-injurious behaviors.
Details
Course Details

Course Originally Released on : 4/26/2021

REL-ACU-0-SB

Course Author

Stephanie Furness

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.